Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000930413-11-001043
Filing Date
2011-02-14
Accepted
2011-02-14 10:31:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 c64353_13g.htm SC 13G 90079
  Complete submission text file 0000930413-11-001043.txt   91920
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45969 | Film No.: 11602922
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2 PICKWICK PLAZA STE 450 GREENWICH CT 06830
Business Address
GREAT POINT PARTNERS LLC (Filed by) CIK: 0001281446 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G